Isolated renal mucormycosis in a transplantation recipient.

[1]  Thomas J Walsh,et al.  Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  A. Kahn,et al.  Primary renal zygomycotic infarction mimicking renal neoplasia in an immunocompetent patient. , 2009, The American journal of the medical sciences.

[3]  D. Kontoyiannis,et al.  Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management. , 2006, Infectious disease clinics of North America.

[4]  D. Loebenberg,et al.  In Vitro Activities of Posaconazole, Fluconazole, Itraconazole, Voriconazole, and Amphotericin B against a Large Collection of Clinically Important Molds and Yeasts , 2006, Antimicrobial Agents and Chemotherapy.

[5]  D. Kontoyiannis,et al.  Epidemiology and outcome of zygomycosis: a review of 929 reported cases. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  Brad Spellberg,et al.  Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management , 2005, Clinical Microbiology Reviews.

[7]  Russell E. Lewis,et al.  Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. , 2005, The Journal of infectious diseases.

[8]  F. Marty,et al.  Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. , 2004, The New England journal of medicine.

[9]  Liu Jianhong,et al.  Isolated renal mucormycosis in children. , 2004, The Journal of urology.

[10]  J. Graybill,et al.  In Vitro Activities of Posaconazole, Itraconazole, Voriconazole, Amphotericin B, and Fluconazole against 37 Clinical Isolates of Zygomycetes , 2002, Antimicrobial Agents and Chemotherapy.

[11]  Lawrence Corey,et al.  Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  K. Gupta,et al.  Ten years' experience in zygomycosis at a tertiary care centre in India. , 2001, The Journal of infection.

[13]  H. Kohli,et al.  Renal zygomycosis: an under-diagnosed cause of acute renal failure. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  G. Verhoef,et al.  Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis , 1999, Bone Marrow Transplantation.

[15]  V. Jha,et al.  Renal mucormycosis: computerized tomographic findings and their diagnostic significance. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  A. Date,et al.  Fungal and nocardial infections of the kidney , 1987, Histopathology.